Invesco’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $175K | Buy |
12,741
+31
| +0.2% | +$425 | ﹤0.01% | 3548 |
|
|
2025
Q1 | $141K | Sell |
12,710
-746
| -6% | -$8.25K | ﹤0.01% | 3572 |
|
|
2024
Q4 | $143K | Buy |
13,456
+634
| +5% | +$6.75K | ﹤0.01% | 3559 |
|
|
2024
Q3 | $163K | Buy |
12,822
+1,159
| +10% | +$14.7K | ﹤0.01% | 3537 |
|
|
2024
Q2 | $196K | Buy |
11,663
+905
| +8% | +$15.2K | ﹤0.01% | 3613 |
|
|
2024
Q1 | $161K | Buy |
10,758
+656
| +6% | +$9.84K | ﹤0.01% | 3673 |
|
|
2023
Q4 | $152K | Buy |
10,102
+47
| +0.5% | +$705 | ﹤0.01% | 3605 |
|
|
2023
Q3 | $141K | Buy |
+10,055
| New | +$141K | ﹤0.01% | 3658 |
|
|
2019
Q1 | – | Sell |
-6,078
| Closed | -$262K | – | 3761 |
|
|
2018
Q4 | $262K | Buy |
+6,078
| New | +$262K | ﹤0.01% | 3461 |
|